Business, News Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA® (inebilizumab) in Brazil by Business Wire • 2022/06/15 • 0 Comments DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics has submitted a regulatory filing for UPLIZNA® in Brazil for NMOSD.